Does Surface Oncology Inc. (NASDAQ:SURF) warrant a purchase right now? What to Consider Before Making a Decision
Surface Oncology Inc. (NASDAQ:SURF) shares traded 0.93% higher at $1.08 on Wall Street last session. In accordance with the data, 5 analysts cover Surface Oncology Inc. (NASDAQ:SURF). The consensus rating among analysts is ‘Hold’. As we calculate the median target price by taking the range between a high of $6.00 and a low of $1.00, […]